Frequency of Adverse Effects of Interferon Treatment in Hepatitis C Patients

Authors: Munazza Ehsan, Muhammad Aslam Rind, Maria Nazir, Muhammad Saleem Rind

1 Liaquat University of Medical Sciences Jamshoro Hyderabad
2 Liaquat University of Medical Sciences Jamshoro Hyderabad Sindh
3 ,Liaquat University of Medical Sciences Jamshoro Hyderabad Sindh
4 Liaquat University of Medical Sciences Jamshoro Hyderabad Sindh

Volume 22 | Issue 2

Published: October 22, 2026

Abstract

Frequency of adverse effects of interferon treatment in Hepatitis C Patients. Study design: Cross sectional descriptive study. Period: Six months setting: Departments of Medicine, Liaquat University of Medical and Health Sciences Jamshoro/ Hyderabad. Material & Methods: 280 patients of hepatitis C undergoing treatment with alpha Interferon were included in the study. Continuous variables such as age, duration of disease, duration of Interferon, were computed as (Mean ± Standard Deviation). Categorical variables such as patient sex,adverse effects such as anemia, neutropenia, thrombocytopenia, hyperthyroidism, hypothyroidism after therapy was presented as frequency and percentage. Post-stratification chi- square test was applied. P<0.05 was taken as significant. The SPSS software version 20 was used for data analysis and evaluations. Results: In our study of 280 patients, the gender distributions was assessed; male 118 (42.1%) and females 162 (57.9%). The mean duration of Interferon treatment was 4.4 months. Hematological adverse effects were assessed and 91(32.5%) patients had neutropenia and 189(67.5%) had normal neutrophil count. The mean level of hemoglobin was 10.3mg/dl, minimum hemoglobin level was 5.00 mg/dl and maximum level was 14.00 mg/dl. Thrombocytopenia was found in 122(43.6%) of patients as per diagnostic criteria. 21 (7.5%) of patients had developed hyperthyroidism. Body Mass Index of the patients were evaluated. Mean BMI of study population was 26.05 Kg/m2 with Std. deviation of 5.6378 Kg/m2 . Minimum BMI was 15Kg/m2 and maximum BMI was 40 Kg/m2 Conclusion: The frequency of adverse effects of Interferon therapy in patients of hepatitis C is an important aspect to be considered. This study suggests that hematological adverse effects are common with Interferon therapy in patients of Hepatitis C.

Keywords: Interferon therapy, hepatitis C, anemia, thrombocytopenia.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF